Prevalence and risk factors for long COVID among cancer patients: a systematic review and meta-analysis.

ABSTRACT:

Objective

The prevalence of long COVID among cancer patients remains unknown. This study aimed to determine the prevalence of long COVID and explore potential risk factors among cancer patients.

Methods

A systematic search was performed on PubMed, Web of Science, and Embase from database inception until 21 March 2024, to identify studies that reported long COVID in cancer patients. Two investigators independently screened the studies and extracted all information about long COVID in cancer patients for subsequent analysis. Methodological quality was assessed using the "Joannagen Briggs Institute (JBI) Critical Appraisal Checklist for Studies Reporting Prevalence Data".

Results

A total of 13 studies involving 6,653 patients were included. The pooled prevalence of long

SUBMITTER: Xu H 

PROVIDER: S-EPMC11774732 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature